Remote heart failure care market seen reaching $5.1 billion by 2033

The global outcome-based remote heart failure care market is projected to grow from $1.78 billion in 2026 to $5.10 billion by 2033, according to Coherent Market Insights. Growth is being driven by more heart failure cases, wider use of remote monitoring, and the shift toward value-based care.

Why it matters: - Remote heart failure care is moving from a niche service to a larger part of chronic disease management. - The market’s projected 16.1% CAGR signals stronger investment in digital cardiac care, connected devices, and outcome-linked reimbursement. - Hospitals and providers are under pressure to reduce avoidable readmissions while improving follow-up after discharge.

What happened: - Coherent Market Insights estimated the global outcome-based remote heart failure care market at $1.78 billion in 2026. - The firm projects the market will reach $5.10 billion by 2033. - The forecast covers the 2026-2033 period and implies a 16.1% CAGR. - The report was released from Burlingame, California. - A sample copy is available here.

The details: - Market growth is tied to rising heart failure prevalence, growing demand for continuous cardiac monitoring, and broader adoption of value-based healthcare. - Healthcare providers are investing in connected monitoring devices, virtual consultations, and AI-powered platforms. - Abbott Laboratories, Medtronic, Philips, Boston Scientific Corporation, GE HealthCare, Cadence, Biofourmis, Health Recovery Solutions, Impulse Dynamics, and BIOTRONIK are listed among the companies covered. - These companies offer cardiac monitoring devices, remote patient management technologies, virtual care platforms, and digital healthcare tools. - By service type, the report includes remote patient monitoring and surveillance, virtual clinical consultation and follow-up, medication management and adherence support, and care coordination and disease management. - By technology type, the report includes remote monitoring devices and wearables, telehealth and virtual care platforms, AI-based predictive analytics and decision support, and digital therapeutics and patient engagement platforms. - By care setting, the report includes home-based care, hospital-based remote care, and ambulatory and outpatient care. - By payment model, the report includes value-based care and bundled payments, shared savings and risk-based contracts, and performance-based and outcome-linked reimbursement. - By end user, the report includes hospitals and health systems, specialty cardiology and heart failure clinics, home healthcare providers, accountable care organizations, and others. - Remote patient monitoring leads the market with a 36.8% share. - Remote monitoring devices and wearables hold a 32.6% share. - Home-based care accounts for 58.4% of the market.

Between the lines: - The market data points to care moving away from episodic hospital visits and toward ongoing supervision at home. - AI-enabled monitoring matters because predictive analytics can flag worsening heart failure earlier and help clinicians prioritize follow-up. - Outcome-based reimbursement supports the business case for tools that can demonstrate measurable improvements in patient health. - North America holds a 42.8% share, supported by advanced cardiovascular infrastructure, remote monitoring adoption, and value-based reimbursement models. - Asia Pacific is the fastest-growing region, with a 22.4% share in 2026 and a projected 18.9% CAGR. - Europe is seeing growth through digital cardiac monitoring and integrated care programs.

What's next: - The U.S. Centers for Medicare & Medicaid Services expanded its ACCESS Model to include heart failure, with the new clinical track scheduled to begin in April 2027. - Philips expanded its patient monitoring ecosystem in August 2026 through collaborations with wearable and remote monitoring technology providers. - The NSW Agency for Clinical Innovation published details of its Virtual Heart Failure Service in January 2026, using a fully virtual care model for post-discharge support. - Coherent Market Insights said the report is intended to help buyers assess market size, forecasts, leading companies, regional investments, and expansion opportunities. - The report also covers competitive landscape analysis, regional forecasts, industry trends, growth opportunities, and Porter’s Five Forces. - The report’s key questions focus on the 2033 market size, dominant services and technologies, leading companies, and high-growth regions. - More information is available in the company announcement.